| __timestamp | MorphoSys AG | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 55962693 | 19586000 |
| Thursday, January 1, 2015 | 78655788 | 29135000 |
| Friday, January 1, 2016 | 95723069 | 42791000 |
| Sunday, January 1, 2017 | 116808575 | 49577000 |
| Monday, January 1, 2018 | 106397017 | 89209000 |
| Tuesday, January 1, 2019 | 108431600 | 69099000 |
| Wednesday, January 1, 2020 | 141426832 | 75961000 |
| Friday, January 1, 2021 | 225200000 | 90467000 |
| Saturday, January 1, 2022 | 297812160 | 74552000 |
| Sunday, January 1, 2023 | 283614139 | 91593000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, innovation is the key to staying ahead. This analysis compares the R&D spending of MorphoSys AG and Supernus Pharmaceuticals, Inc. from 2014 to 2023. Over this period, MorphoSys AG consistently outspent Supernus Pharmaceuticals, with an average R&D expenditure nearly 140% higher. Notably, MorphoSys AG's R&D spending peaked in 2022, reaching almost three times its 2014 levels, highlighting a robust commitment to innovation. In contrast, Supernus Pharmaceuticals showed a steady increase, with a notable 367% rise from 2014 to 2023. This trend underscores the growing emphasis on research and development in the pharmaceutical sector, as companies strive to bring groundbreaking therapies to market. As the industry continues to face challenges and opportunities, these investments in R&D are crucial for future success.
Research and Development: Comparing Key Metrics for Pfizer Inc. and MorphoSys AG
R&D Insights: How Zoetis Inc. and Supernus Pharmaceuticals, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Genmab A/S and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Insmed Incorporated and Supernus Pharmaceuticals, Inc.
Comparing Innovation Spending: Jazz Pharmaceuticals plc and MorphoSys AG
Who Prioritizes Innovation? R&D Spending Compared for Pharming Group N.V. and MorphoSys AG
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs Supernus Pharmaceuticals, Inc.
Alkermes plc vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Perrigo Company plc vs MorphoSys AG
Analyzing R&D Budgets: Vericel Corporation vs Supernus Pharmaceuticals, Inc.
Comparing Innovation Spending: ImmunityBio, Inc. and Supernus Pharmaceuticals, Inc.